The Journal of Feline Medicine and Surgery recently published the results of a study about the present and potential clinical applications of mesenchymal stem cell therapy in cats. The study focused on the emergence of this new therapeutic strategy and the current understanding of the biology and immunology of mesenchymal stem cells. Researchers summarized promising outcomes of clinical trials that have focused on the use of mesenchymal stem cells in the treatment of inflammatory, degenerative and immune-mediated diseases in cats.
Source: Tufts Catnip, May 2018. Link.
Trials of stem cell therapy for feline chronic gingivostomatitis — a severe, painful oral disease believed to affect up to 12 percent of cats presented to veterinary practices — have produced encouraging results. There have been positive results too for conditions like inflammatory bowel disease (IBD) and asthma. The treatment has been generally well tolerated, with relatively few side effects and even curative in some cases.